Submitted by pharmamanufacturing on Fri, 12/16/2011 - 16:03.
This year, we introduced our Pharma Replay newsletter, a monthly review of the best quips and quotes coming out of the drug industry. (Subscribe here.) Here’s a look back, in no particular order, at the best quotes of 2011. From these quotes, it appears it was a rough year for J&J, and for jobs.
Submitted by pharmamanufacturing on Tue, 09/27/2011 - 15:28.
Bayer and its workers in Berkeley, California, are embroiled in protracted contract negotiations. Last week, we heard from Craig Merrilees, spokesman for the International Longshore & Warehouse Union (ILWU), which represents the workers. Bayer owes workers and the community more, said Merrilees, and worker patience with the company is “wearing thin," he said.
Submitted by pharmamanufacturing on Wed, 11/17/2010 - 20:47.
Most of the U.S. Department of Justice’s major pharma-related decisions invoking the False Claims Act recently have involved illegal marketing and sales. So far, GSK’s is the only one to deal with current good manufacturing practices (cGMP’s). Read on for a roundup of the top 20 recent cases from Taxpayers Against Fraud (TAF).
Submitted by pharmamanufacturing on Thu, 11/04/2010 - 21:22.
A growing number of pharma CEOs are now dealing with the consequences of failing to care about workplace realities and what Toyota called the gemba, or place where truth will be found.
If the idea of reading a book on ethics or philosophy is too off-putting....after all, it has been a rough week....why not simply listen to The Clash's hit song "Should I Stay or Should I Go?" The answer's right there. "If I go there will be trouble, and if I stay it will be double." From 'On Pharma'
Submitted by pharmamanufacturing on Thu, 11/04/2010 - 02:37.
Pharma whistleblowers don't always fare too well...especially those who deal with the invisible world of manufacturing. Remember Mark Livingston and the Wyeth Sarbanes-Oxley case? However, Cheryl Eckard, who pointed out manufacturing deficiencies at GSK's Cidra, Puerto Rico, plant has received a $96-million payment. For more from The Guardian, read on. They've included
Submitted by pharmamanufacturing on Wed, 10/27/2010 - 19:41.
Cautionary tale for execs in pharma (or any industry) on the limits of "doing more with less," ignoring technical operations and focusing on financial balance sheets at the expense of quality and safety. Frontline's documentary on the BP disaster and Texas City refinery tragedy.
Submitted by pharmamanufacturing on Wed, 02/24/2010 - 22:42.
I recently interviewed Michelle Alton, a senior pharma professional who is in the middle of a job search. The market is tough out there, she says, and networking is key.
Submitted by pharmamanufacturing on Fri, 02/05/2010 - 15:36.
Recent postings in the WSJ blog and elsewhere have asked the troubling question: Does Lean Manufacturing, by definition, lead to quality control problems? Click here for an interesting read. (For something that doesn't require registration, click here.)
Submitted by pharmamanufacturing on Wed, 10/21/2009 - 22:41.
Ever get stuck behind a loud bore on an airplane? I had that misfortune last week. Eventually tuned him out, but couldn’t help but pity his quiet seat-mate, who didn’t know a peptide from a Pepsi, as he got sucked deeper and deeper into a one-sided verbal black hole, a diatribe about the axis of evil: the pharmaceutical industry and its “ally,” the FDA.
This bore was well-read, but essential bits of knowledge were missing from everything he talked about, from his description of peptides and how cox-2 inhibitors work to his characterization of the evil FDA.
I recently interviewed Michelle Alton, a senior pharma professional who is in the middle of a job search. The market is tough out there, she says, and networking is key.
